- Anglo-Dutch food giant Unilever will help Phytopharm develop snacks containing Hoodia extract.
- A slimming aid made from a southern African cactus is set to be developed by UK firm Phytopharm and Unilever.
- Phytopharm will receive an initial fee of £6.5m from Unilever - out of a potential total of £21m - as well as future royalties on product sales.
- Production of the Hoodia cactus at Phytopharm's nursery in South Africa will also rise from eight million plants to potentially hundreds of millions.
- The firm had initially hoped to market a slimming drug from Hoodia with Pfizer.
